Human Pulmonary Artery Smooth Muscle Cells: HPASMC
Description
Human Pulmonary Artery Smooth Muscle Cells (HPASMC) from Cell Applications, Inc. have been used to show that:
- Antitumor drugs can selectively target remodeled pulmonary vessels, but not normal vessels
- Serotonin induces their growth and activates the BMP receptor
- IL-22 promotes the growth of pulmonary vascular SMCs via a signaling mechanism that involves NADPH oxidase-dependent oxidation
- Inducers of pulmonary hypertension, characterized by thickened pulmonary arterial walls, can be suppressed by targeting gene transcription
- Cell growth can be suppressed by trans-retinoic acid by inducing expression of a known cell growth suppressor,
- Retinoic acid and its receptors may be involved in cell growth and pulmonary vascular remodeling
- Iron chelation exerts effects on vascular remodeling and is implicated for development of pulmonary hypertension as a result of ROS activity
Characterization:Â positive for smooth muscle cell specific alpha-actin expression
Details
Tissue | Normal healthy human pulmonary artery | |
---|---|---|
QC | No bacteria, yeast, fungi, mycoplasma, virus | |
Character | Smooth muscle specific α-actin positive | |
Bioassay | Attach, spread, proliferate in Growth Med | |
Cryovial | 500,000 HPASMC frozen in Basal Medium w/ 10% FBS, 10% DMSO | |
Kit | Cryovial frozen HPASMC (352-05a), Growth Medium (311-500), Subcltr Rgnt Kit (090K) | |
Proliferating | Shipped in Gr Med, 3rd psg (flasks or plates) | |
Doublings | At least 16 | |
Applications | Laboratory research use only (RUO). Not for human, clinical, diagnostic or veterinary use. |
Resources
FAQs
Need More Help?
Visit our comprehensive FAQ page for detailed answers to common questions.
Need More Help?
Visit our comprehensive FAQ page for detailed answers to common questions.
Primary Cell FAQs